2025 Patient and Family Conference Session: MDS and MPNs
In this recording, Dr. Catherine Lai discusses MDS and how patients can also be diagnosed with MPN's. Her presentation discusses the treatment options available to patients and resources.
patient
2025 Rockville Patient and Family Conference: Debra's Story - Aplastic Anemia
2025 Rockville Patient and Family Conference: Low Risk MDS
In this recording, Dr. Ball Brian discusses low risk MDS and current treatment options.
2025 Rockville Patient and Family Conference Session: MDS and Transplant
In this recording, Dr. Parveen Shiraz discusses transplant for MDS and potentials complications such as GVHD and treatment options.
2025 Rockville Patient and Family Conference Session: Aplastic Anemia
2025 Rockville Patient and Family Conference: PNH Complications with Philip Scheinberg
In this recording, Dr. Philip Scheinberg discusses PNH complications that can impact a patient - extravascular hemolysis, intravascular hemolysis,
MDS/MPN Overlap
In this webinar, Dr. David Sallman discusses the diagnosis of MDS and MPN, treatment options available to patients and symptom management.
Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT
For patients with myelodysplastic neoplasm/syndrome (MDS), allogeneic hematopoietic cell transplantation (allo-HCT) represents the only potentially curative treatment, capable of eradicating disease-related mutant hematopoietic cells and establishing normal donor hematopoiesis.
How is transfusion dependence evolving in anemia treatment in MDS?
A roundtable discussion on anemia management in
Jane Biehl: Moving Slower and Slower After Myelodysplastic Syndrome
I have honestly been frustrated lately. I am slowing down increasingly, and it has even become noticeable to others. I wrote an article in November about how nice it was to slow down and smell the roses. But now it seems like too much.